From: Early diagnostic value of survivin and its alternative splice variants in breast cancer
Survivin ELISA | ER + PR + Her2- | ER-PR-Her2- | ER + PR + Her2+ |
---|---|---|---|
Moderate to high (70 pg/ml) | 19 (83%) | 6 (86%) | 1 (50%) |
Low normal to mild (<50 pg/ml) | 4 (17%) | 1 (14%) | 1 (50%) |
Total | 23 | 7 | 2 |